OasisLMS

• Identify At-Risk Patients: Learn to recognize patients with risk factors for MASLD and MASH, including those with prediabetes, diabetes, obesity, and other metabolic comorbidities.
• Non-Invasive Screening Techniques: Utilize current non-invasive tests to enhance early screening efforts and identify when specialist referrals are necessary.
• Data Interpretation: Implement and refine the interpretation of non-invasive test data for optimal management strategies and patient follow-up.
• Emerging Therapies: Discover existing and emerging pharmacotherapies that can improve outcomes for MASLD, MASH, and associated comorbidities.
  

Learning Objectives:

Upon successful completion of the program, participants should be able to:

• Identify patients with risk factors for MASLD.
• Utilize currently available non-invasive tests for early screening and identify when referrals to specialists are needed.
• Implement and improve data interpretation of non-invasive tests for best management strategies and follow-up of patients.
• Identify existing and emerging pharmacotherapies that can assist in improving both MASLD and MASH and other comorbidities.
  
  

Format:
Lectures
Patient Cases

 

Tagret Audience:

This educational program is ideal for healthcare professionals involved in the care of patients at risk for MASLD and MASH, including:

• Endocrinologists
• Primary Care Physicians (PCPs)
• Advanced Practice Professionals (Nurse Practitioners [NPs], Physician Assistants [PAs]
  
  

 

Upon successful completion of the program, participants should be better able to:

• Identify patients with risk factors for MASLD.
• Utilize currently available non-invasive tests for early screening and identify when referrals to specialists are needed.
• Implement and improve data interpretation of non-invasive tests for best management strategies and follow-up of patients.
• Identify existing and emerging pharmacotherapies that can assist in improving both MASLD and MASH and other comorbidities.

 

This educational program is ideal for healthcare professionals involved in the care of patients at risk for MASLD and MASH, including:

• Endocrinologists
• Primary Care Physicians (PCPs)
• Advanced Practice Professionals (Nurse Practitioners [NPs], Physician Assistants [PAs]

Physicians and Physician Assistants 
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.  

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.

Nurses 
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 3.5 contact hours.

This activity is supported by independent educational grants from Novo Nordisk and Siemens Medical Solutions

https://my.aace.com/NC__Product?id=a1BPo0000037fntMAA

FREE

ENDO, PCP, NP, PA